As of 31 Dec 2025, 1 institutional investors reported holding 14,000 shares of LianBio - COM (LIANY).
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 14,000 | $1,000 | +$1,000 | $0.07 | 1 |
| 2025 Q3 | 0 | $0 | -$5,000 | $0.07 | 0 |
| 2025 Q2 | 14,000 | $5,000 | -$250 | $0.36 | 1 |
| 2025 Q1 | 14,700 | $2,000 | -$39,078 | $0.14 | 1 |
| 2024 Q4 | 161,921 | $42,146 | +$85 | $0.24 | 2 |
| 2024 Q3 | 161,521 | $47,282 | $0.29 | 2 | |
| 2024 Q2 | 161,521 | $50,532 | +$2,290 | $0.30 | 2 |
| 2024 Q1 | 153,878 | $49,245 | -$377,300,266 | $0.32 | 3 |
| 2023 Q4 | 84,425,031 | $377,349,511 | +$42,923,042 | $4.47 | 29 |
| 2023 Q3 | 79,009,362 | $117,721,830 | -$5,214,795 | $1.49 | 37 |
| 2023 Q2 | 80,209,284 | $182,875,955 | +$361,472 | $2.28 | 38 |
| 2023 Q1 | 80,205,299 | $157,109,504 | -$440,193 | $1.96 | 35 |
| 2022 Q4 | 81,273,729 | $133,279,839 | -$5,354,646 | $1.64 | 39 |
| 2022 Q3 | 84,038,211 | $167,965,143 | -$6,038,961 | $1.99 | 43 |
| 2022 Q2 | 86,612,279 | $187,087,347 | +$526,051 | $2.16 | 44 |
| 2022 Q1 | 85,948,354 | $318,649,689 | -$21,475,556 | $3.71 | 36 |
| 2021 Q4 | 89,425,687 | $550,450,000 | +$550,449,954 | $6.16 | 36 |